Sem cell transplantation in ALL
Updated: 2009-11-26 22:40:56
Maintenance cisplatin IV after cisplatin/gemcitabine for bladder cancer
Updated: 2009-11-26 20:52:28Admission for coronary syndrome
Updated: 2009-11-26 15:26:23Tarceva for head and neck cancer
Updated: 2009-11-25 09:14:54Revlimid for AML with 13q abnormality.
Updated: 2009-11-22 01:54:00Temodar and Xeloda for neuroendocrine cacner
Updated: 2009-11-20 16:55:21Role of 5FU is pancreatic cancer progressing after gemcitabine
Updated: 2009-11-20 10:56:01A disappointing decision on liver cancer treatment
Updated: 2009-11-19 14:54:58
NICE’s decision today not to recommend sorafenib – also known as Nexavar – to the NHS for the treatment of advanced liver cancer, is deeply disappointing for a number of reasons – namely the drug’s cost; the fact that it works; the questions this raises over NICE’s processes; and the effect this has on public [...]Rebuilder Neuropathy Treatment System TENS for chemotherapy induced neuropathy
Updated: 2009-11-19 06:43:27Xeloda combinations for thymoma
Updated: 2009-11-18 03:18:10Patient information – providing for cancer patients outside the hospital
Updated: 2009-11-18 00:27:53A diagnosis of cancer can be a confusing time, where a lot of new information can arrive very quickly.
Patients can, of course, discuss things with their doctor whilst they’re in hospital or when they visit their GPs. But it can also be enormously reassuring to speak to someone else at a later date, under your [...]ASHAP for salvage for Hodgkin's
Updated: 2009-11-16 01:36:41We urgently need the government to act on sunbeds
Updated: 2009-11-13 16:54:47Today we published research in the British Medical Journal that looked at sunbed use amongst teenagers in England. The research has been widely covered in the media – and our spokespeople have had a busy morning being interviewed for local and national television and radio.
Our findings are stark. Young people across England say they’re using [...]The Health Bill becomes law – tobacco is now out of sight!
Updated: 2009-11-13 16:06:35
After almost a year and a half of campaigning, measures to help protect children from tobacco marketing were yesterday enshrined into law.
The Health Bill 2009, which bans the display of tobacco at the point of sale and prohibits tobacco vending machines received Royal Assent yesterday evening and became the Health Act 2009.
Since August last [...]NCRI Cancer Conference 2009: a review
Updated: 2009-11-11 10:56:56Regular readers of this blog will have noticed a flurry of posts over the past month covering the 2009 NCRI Cancer Conference, which took place at the beginning of October. Such events are a fantastic opportunity to hear about the latest research and exciting new strategies to beat cancer.
In this short video, the conference’s scientific [...]NCRI Cancer Conference: Infections and cancer
Updated: 2009-11-10 17:28:33Over the years, it’s become apparent that certain viruses, bacteria and parasites can cause cancer, as exemplified by the Human papillomavirus, or HPV, which is implicated in cervical cancer and now subject of the new vaccination programme for teenage girls in the UK.
What many people don’t realise is that nearly 20 per cent of all [...]Sprycel for glioblastoma
Updated: 2009-11-06 21:17:47Hypercoagulability testing in asymptomatic patients with a family history.
Updated: 2009-11-06 14:59:38Home ‘prostate screening’ kits – are they reliable?
Updated: 2009-11-06 13:28:27You may have seen news this week that a batch of home test kits that allegedly screen for prostate cancer has been recalled, because they weren’t giving accurate results.
These test kits, like the ones that are available through GPs, are designed to measure the level of a protein called PSA in the blood. They’re meant [...]NCRI Cancer Conference 2009: A new dawn – Monoclonal antibodies
Updated: 2009-11-06 09:38:44
There are so many different types of cancer drugs coming into the clinic that it can sometimes be hard to keep up. Among the most exciting additions in the last decade are monoclonal antibodies (mAbs) – Herceptin and rituximab are two examples.
Rituximab was the first mAb to be licensed in the UK. It has transformed [...]NCRI Cancer Conference 2009: Stopping cancer in its tracks
Updated: 2009-11-05 13:53:55
Cancer cells can invade their surrounding tissues and spread – or metastasise – to other parts of the body. Once this happens, cancer is much more difficult to successfully treat. In fact, it is estimated that around 9 out of 10 cancer deaths are due to cancer that has spread.
Recently, the advent of new, cutting-edge [...]Followup after resection of bladder cancer
Updated: 2009-11-05 10:30:33Sorry it took so long
Updated: 2009-11-05 07:32:18First of all, I might need to say this again, since some people seem to still be thinking this, but I am not cancer free. I am merely tumor free. It has been nearly two months since I have written a post on here, and that was one in which I promised to write more [...]